Detected ·
Nouscom
——
Neva SGR invests in Nouscom, a clinical-stage biotech developing next-gen cancer immunotherapy, to support advancement of NOUS-209 for Lynch syndrome carriers.
- Website
- —
- linkedin.com/company/18328527
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-20 04:04:48 UTC
- Signal ID
- 6e95d7f0-3232-4748-b455-a4217f1b1f28
As the API returns it
{
"id": "6e95d7f0-3232-4748-b455-a4217f1b1f28",
"created_at": "2026-10-20T04:04:48.105838Z",
"company_name": "Nouscom",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/18328527",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Neva SGR invests in Nouscom, a clinical-stage biotech developing next-gen cancer immunotherapy, to support advancement of NOUS-209 for Lynch syndrome carriers.*"
}